Sign Up to like & get
recommendations!
0
Published in 2020 at "Microbial Drug Resistance"
DOI: 10.1089/mdr.2019.0298
Abstract: Therapeutic options for the treatment of infections owing to multidrug-resistant Gram-negative pathogens are often limited. Cefiderocol is a novel siderophore cephalosporin with activity against Gram-negative pathogens, including many multidrug-resistant strains. The activity of cefiderocol was…
read more here.
Keywords:
pseudomonas aeruginosa;
enterobacterales pseudomonas;
activity cefiderocol;
cefiderocol ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.00965-20
Abstract: The SuperCAZ/AVI medium was developed for screening ceftazidime-avibactam (CZA) resistance among Gram-negative bacteria (Enterobacterales and Pseudomonas aeruginosa). It was evaluated using 50 CZA-susceptible and 42 CZA-resistant Gram-negative isolates. Its sensitivity and specificity of detection were…
read more here.
Keywords:
enterobacterales pseudomonas;
medium;
cza;
resistance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.01158-22
Abstract: Clinicians often base antimicrobial therapeutic decisions on laboratory determinations of pathogen susceptibility to an antibiotic based on MIC breakpoints. MIC breakpoints evolve over time based on new information; between 2010 and 2012 the CLSI lowered…
read more here.
Keywords:
ipm mem;
enterobacterales pseudomonas;
facility reported;
pseudomonas aeruginosa ... See more keywords